An engineered E. coli strain survived after one amino acid was designed out of many of its ribosomal proteins—an early test ...
Cancer cells carry thousands of mutations, but not all mutations are created equal. Some make tumors highly visible to the immune system, while others help cancers hide. In this study, researchers ...
Amivantamab with lazertinib for untreated EGFR mutation-positive advanced non-small-cell lung cancer
Amivantamab plus lazertinib can be used, within its marketing authorisation, as an option for untreated advanced non-small-cell lung cancer (NSCLC) in adults whose tumours have epidermal growth factor ...
This mutation was first identified in an American kindred from the Midwest with at least 10 affected family members over four generations known as FTD004 (Hutton et al., 1998). The mutation was ...
Abstract: A number of methods have been proposed over the last decade for encoding information using deoxyribonucleic acid (DNA), giving rise to the emerging area of DNA data embedding. Since a DNA ...
Abstract: Correlated mutations in proteins are believed to occur in order to preserve the protein functional folding through evolution. Their values can be deduced from sequence and/or structural ...
This study provides an important method to model the statistical biases of hypermutations during the affinity maturation of antibodies. The authors show convincingly that their model outperforms ...
The prevalence of G6PD deficiency differs among ethnic groups. For instance, males of African and Mediterranean descent more frequently express the trait. Two types of mutations are commonly found in ...
Osimertinib with pemetrexed and platinum-based chemotherapy is recommended, within its marketing authorisation, as an option for untreated advanced non-small-cell lung cancer (NSCLC) in adults whose ...
This short article uses mutation counts in phylogenies of millions of SARS-CoV-2 genomes to show that mutation rates systematically differ between regions that are paired or unpaired in the predicted ...
A comprehensive analysis of over 500,000 human protein variants reveals that 60% of disease-causing missense mutations reduce protein stability In a recent study published in Nature, researchers used ...
Johnson & Johnson (J&J) has announced that its chemotherapy-free combination has been approved by the European Commission (EC) for a subset of epidermal growth factor receptor (EGFR)-mutated lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results